clinicaltrialsarena5h
Pfizer’s colon cancer combo approval further supported by Phase III win
The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.
clinicaltrialsarena5h
Pharma companies will continue to push for diversity, experts say
Experts believe that pharma will continue as normal due to the scientific justification of running diverse clinical trials.
clinicaltrialsarena7h
IIT Guwahati researchers develop new trial method for personalised care
In partnership with global institutions, IIT Guwahati researchers have developed an adaptive multi-stage trial method.
clinicaltrialsarena9h
2021 was the leading year in rare disease trials
According to leading data and analytics company GlobalData’s Clinical Trials Database, over the past 20 years trial activity ...
clinicaltrialsarena9h
Inhalon launches human challenge trial for RSV treatment
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
clinicaltrialsarena10h
OCT Medical Devices 2025: AI’s value appreciable, yet human touch remains key
Medical Devices conference, held in Munich, Germany on 28-29 January, was filled with sessions that dug into the minutiae of ...
clinicaltrialsarena10h
Advanced Clinical chosen as CRO for Paradigm’s Phase III osteoarthritis trial
Paradigm Biopharmaceuticals has selected Advanced Clinical as the CRO to support its Phase III trial, PARA_OA_012, focused on ...
clinicaltrialsarena12h
University of Birmingham study finds digoxin may aid in managing heart failure
A study from the University of Birmingham has indicated that digoxin could be used to treat senior individuals with heart ...